Immune to Cancer: The CRI Blog
-
Multiple Myeloma Awareness Month: 2022 Immunotherapy Research Updates
This March for Multiple Myeloma Awareness Month, discover the latest treatments, research insights, and progress for a…
-
Dr. Hearn Jay Cho Answers Questions About Blood Cancer And Immunotherapy After the 2021 CRI Virtual Immunotherapy Patient Summit
Dr. Hearn Jay Cho, of Mount Sinai Tisch Cancer Institute, answers questions about blood cancer and immunotherapy…
-
Blood Cancer Awareness Month: 2021 Immunotherapy Research Updates
This September for Blood Cancer Awareness Month, discover new research, treatments, and how CRI is making strides…
-
Multiple Myeloma Awareness Month: 2021 Immunotherapy Research Updates
This March for Multiple Myeloma Awareness Month, we look at new research, new treatments, and how we’re…
-
Blood Cancer Awareness Month: 2020 Immunotherapy Research Updates
This September for Blood Cancer Awareness Month, we look at how we’re working toward a future immune…
-
How COVID-19 is Impacting Care for Blood Cancer Patients
CRI spoke with Dr. Melody Smith about how clinical care for leukemia, lymphoma, and multiple myeloma patients…
-
Multiple Myeloma Awareness Month: 2020 Immunotherapy Research Update
New FDA approvals, brilliant researchers, and how we’re working toward a future immune to multiple myeloma.
-
ASH18 Preview: Blood Cancer Immunotherapy Developments at 60th American Society of Hematology Meeting
The 2018 American Society of Hematology meeting will showcase a variety of basic and clinical advances in…
-
Immunotherapy Shines at ASH and ESMO IO Conferences
Two conferences, one in America and one in Europe, highlight immunotherapy's continued progress and the important contributions…